CV Risks and Gout T2T - An Interview with Dr. Seoyoung Kim Save
Dr. Kathryn Dao interviews Dr. Kim, recipient of this year's ACR Henry Kunkel Early Career Investigator Award, about how she got into medical research, and her work in CV risk in hydroxychloroquine (abstract L11), gout T2T and CV outcomes (abstract L06), and, CV outcomes in tofacitinib (abstract 1939).
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.